International Stem Cell Corp.

0.1350

-0.0100-6.90%

Volume:514.00

Turnover:69.39

Market Cap:1.08M

PE:-7.26

High:0.1350

Open:0.1350

Low:0.1350

Close:0.1450

52wk High:0.2726

52wk Low:0.0820

Shares:8.00M

Float Shares:3.70M

Volume Ratio:3.06

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0186

EPS(LYR):-0.3336

ROE:-15.07%

ROA:1.16%

PB:-0.29

PE(LYR):-0.40

Loading ...

Overview Company News Filings

International Stem Cell Corporation Held Annual Shareholder Meeting

Reuters

·

Nov 19, 2025

International Stem Cell Corporation reports $2.4 million product revenue for Q3 2025

Reuters

·

Nov 14, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ISCO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ISCO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ISCO\",,,,,undefined,":{"symbol":"ISCO","market":"US","secType":"STK","nameCN":"International Stem Cell Corp.","latestPrice":0.135,"timestamp":1771880400000,"preClose":0.145,"halted":0,"volume":514,"delay":15,"changeRate":-0.06896551724137918,"floatShares":3700521,"shares":8004389,"eps":-0.0186,"marketStatus":"Post-Mkt","change":-0.01,"latestTime":"02-23 16:00:00 EST Delay","open":0.135,"high":0.135,"low":0.135,"amount":69.39,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.0186,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771894800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.145,"volumeRatio":3.063173},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ISCO\",,,,,undefined,":{"symbol":"ISCO","floatShares":3700521,"roa":"1.16%","roe":"-15.07%","lyrEps":-0.333594,"volumeRatio":3.063173,"shares":8004389,"dividePrice":0,"high":0.135,"amplitude":0,"preClose":0.145,"low":0.135,"week52Low":0.082,"pbRate":"-0.29","psRate":"0.12","week52High":0.2726,"institutionHeld":0,"latestPrice":0.135,"eps":-0.0186,"divideRate":0,"volume":514,"delay":15,"ttmEps":-0.0186,"open":0.135,"prevYearClose":0.14,"prevWeekClose":0.145,"prevMonthClose":0.14,"prevQuarterClose":0.14,"fiveDayClose":0.175,"twentyDayClose":0.16,"sixtyDayClose":0.1495},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ISCO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-13","symbol":"ISCO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-14","symbol":"ISCO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-28","symbol":"ISCO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-08-12","symbol":"ISCO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1660276800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2020-06-19","symbol":"ISCO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1592539200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ISCO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ISCO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ISCO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584969785","title":"International Stem Cell Corporation Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2584969785","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584969785?lang=en_us&edition=fundamental","pubTime":"2025-11-19 06:18","pubTimestamp":1763504313,"startTime":"0","endTime":"0","summary":"International Stem Cell Corporation held its Annual Meeting of Stockholders on June 17, 2025. Stockholders elected Andrey Semechkin, Russell Kern, Donald A. Wright, and Paul V. Maier to the board of directors. Stockholders also approved an advisory vote on executive compensation. In addition, stockholders voted in favor of holding future advisory votes on executive compensation every three years.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. International Stem Cell Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 18, 2025, and is solely responsible for the information","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL6Svw6z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ISCO","BK4139"],"gpt_icon":0},{"id":"2583511466","title":"International Stem Cell Corporation reports $2.4 million product revenue for Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2583511466","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583511466?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:02","pubTimestamp":1763067751,"startTime":"0","endTime":"0","summary":"International Stem Cell Corporation reported product sales of $2.4 million for the three months ended September 30, 2025, up 9% from $2.2 million in the same period in 2024. For the nine months ended September 30, 2025, product sales were $6.9 million compared to $6.6 million for the prior year period. Net income for the quarter was $57 thousand, compared to a net loss of $125 thousand in the same quarter last year. The increase in product sales was attributed to growth in the Biomedical market segment, particularly from cells and other product sales, partially offset by decreases in media product sales and in the skin care product line. The company reported no revenue generated from its principal therapeutic and clinical product development operations during the period.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL9nGrxl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ISCO"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}